Skip to content
healthcare services hero image
healthcare services hero image

Healthcare Services

Allen & Overy can provide legal services creating a solid foundation for your healthcare infrastructure projects.

Development and provision of specialised healthcare infrastructure is one of the key themes in modern times and requires specialist advice. The unique issues raised by the public service nature of hospitals, nursing homes, rehabilitation centres, clinics, academic and commercial R&D facilities always challenge investors, sponsors and lenders. As a global firm, we can successfully guide you through all stages of the lifecycle of healthcare infrastructure projects. In the healthcare infrastructure sector, we regularly advise on lettings and leasings, development, planning and construction, environmental issues and implications, private/public partnerships, including public procurement, transitional employment issues, commercial agreements with stakeholders, outsourcing, data protection and privacy, strategic licensing and collaboration agreements, global joint ventures, M&A and restructuring.

News & insights

Publications: 30 MARCH 2020

China’s life sciences industry remains opportune despite Covid-19 coronavirus

While the novel Covid-19 coronavirus is at the top of the agenda for businesses around the world, and for good reason, it is creating challenges for medical and healthcare systems and signalling fundamental change across the life sciences industry. 

Read more
coronavirus

Publications: 16 MARCH 2020

Coronavirus - what is the current situation in Germany?

In order to contain the Coronavirus the German federal states as well as the German government have put strict measures into place. Schools and kindergartens have been closed as well as borders to most neighbouring states for private travel. In order to mitigate the economic consequences, the German government announced a comprehensive package of measures.

Read more

Publications: 19 FEBRUARY 2020

Phase One Sino–U.S. trade agreement and the pharmaceutical industry

On 16 January 2020, China and the United States signed the Economic and Trade Agreement between the Government of the People’s Republic of China and the Government of the United States of America (the Phase One Trade Agreement).

Read more

Publications: 02 SEPTEMBER 2019

China: amendment to Drug Administration Law

On August 26, 2019, the China’s National People’s Congress passed the amended Drug Administration Law (the Amended DAL) which will take effect on December 1.

Read more

Download our sector brochure

Life sciences A&O red molecules

An insight in to our Life Science and Healthcare sector 2019

Our global Life Sciences and Healthcare sector comprises a multi-disciplinary team. We act for companies and their investors across the industry, including in the pharmaceuticals, biotech, animal health, consumer health, med tech, and diagnostics sectors.

Related expertise